FIELD: chemistry.
SUBSTANCE: invention relates to a compound of a tricyclic derivative of chemical formula 1, or a pharmaceutically acceptable salt thereof, or a stereoisomer, which have high inhibitory action on serotonin activity. Values of X and R in chemical formula 1 are given in the claim. Invention also relates to a specific compound, which is a tricyclic derivative, a pharmaceutical composition for preventing or treating diseases associated with serotonin activation, containing said compounds, embodiments of their use, methods of preventing or treating diseases associated with activation of serotonin, and inhibiting serotonin activity using them. 1].
EFFECT: disclosed is a tricyclic compound and its pharmaceutical use.
14 cl, 2 tbl, 74 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUND FOR DESTRUCTION OF ANDROGEN RECEPTOR AND ITS PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2817356C1 |
| IMIDAZOPYRIDINE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO HISTAMINE H | 1992 |
|
RU2114845C1 |
| NOVEL HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2018 |
|
RU2733384C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| ANTIINFECTIVE COMPOUNDS | 2011 |
|
RU2576662C2 |
| COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788147C2 |
| NOVEL COMPOUNDS OF CONDENSED HETEROCYCLYL-CARBOHYDRAZONOYL DICYANIDES AND USE THEREOF | 2021 |
|
RU2826002C1 |
| NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2021 |
|
RU2817736C1 |
| 1,3,4-OXADIAZOLE SULPHONAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS 6 AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2016 |
|
RU2697665C1 |
